BIOLOGY AND BIOTECHNOLOGY
ADXN Announces Q3 2026 Financial Results Call - ADXN
Addex Therapeutics will report its Q3 2026 financial results on November 25. CEO Tim Dyer will provide a business update during the call.
SWITZERLANDGENTTSUKUBADIPRAGLURANTADXNNEUROSTERIX US HOLDINGS LLC